Last updated on September 2018

Evaluation of SPN-812 ER High Dose in Adolescents With ADHD

Brief description of study

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old).

Clinical Study Identifier: TX211879

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.